Si Young Sung

Title: Innovations of Si Young Sung in Pharmaceutical Chemistry

Introduction

Si Young Sung is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrrolylheptanoic acid derivatives. His research has led to advancements that can potentially enhance the stability and efficacy of pharmaceutical compositions.

Latest Patents

Si Young Sung holds a patent for "Crystal forms of pyrrolylheptanoic acid derivatives." This invention provides novel crystalline forms D and D of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt, and hydrates thereof. The crystalline forms exhibit X-ray powder diffraction peaks that are detailed in the accompanying figures. Furthermore, the invention outlines processes for preparing these crystalline forms and pharmaceutical compositions that include them. These forms can be produced on a commercial scale and demonstrate excellent stability.

Career Highlights

Si Young Sung is currently associated with Dong-a Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of drug formulation.

Collaborations

Si Young Sung has collaborated with notable colleagues, including Moon Sung Kim and Moo Hi Yoo. These partnerships have fostered a collaborative environment that enhances research and development efforts within the company.

Conclusion

Si Young Sung's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in drug stability and efficacy.